Skip to main content


Latest articles

12-08-2022 | Rheumatology | News | Article

Pioglitazone may modulate CVD risk in patients with SLE

Pioglitazone, a peroxisome proliferator activated receptor-γ agonist, is associated with improvements in vascular stiffness and various cardiometabolic parameters in patients with systemic lupus erythematosus, show study findings.

11-08-2022 | Rheumatology | News | Article

Updated European guidance on vaccination issued for pediatric rheumatology patients

Click through for more details on the EULAR recommendations

11-08-2022 | Rheumatology | News | Article

Ustekinumab approved for pediatric PsA in the USA

Click through for further information on this expanded indication

09-08-2022 | Rheumatology | News | Article

Substantial lifetime risk for axSpA among relatives of patients with ankylosing spondylitis

A 35-year follow-up study has identified a 27.1% lifetime recurrence rate of axial spondyloarthritis among first-degree relatives of patients with human leukocyte antigen HLA-B27-positive ankylosing spondylitis.

08-08-2022 | Rheumatology | News | Article

Impaired right ventricular function could signal high risk for poor outcomes in SSc patients

Measures of right ventricular function could provide “crucial information” to predict which patients with systemic sclerosis are at high risk for poor outcomes, researchers report in Arthritis Research & Therapy.

05-08-2022 | Rheumatology | News | Article

Support for long-term use of biologics in people with HIV

TNF inhibitors have good long-term effectiveness and are well tolerated in HIV-positive individuals with rheumatic diseases, researchers report.

Man with painful and swollen right foot due to gout inflammation (symbolic image with model)

04-08-2022 | Rheumatology | Highlight | Article

Gout flares linked to temporary increase in cardiovascular risk

Gout flares are associated with an increased risk for cardiovascular events in the following 120 days, study findings suggest.

02-08-2022 | Rheumatology | News | Article

Sequential rituximab, mepolizumab regimen may warrant further investigation for EGPA

Sequential treatment with rituximab followed by mepolizumab may be a promising strategy to treat the systemic and respiratory manifestations of eosinophilic granulomatosis with polyangiitis, suggest findings from an observational study.

01-08-2022 | Rheumatology | News | Article

Voclosporin set for EMA approval for lupus nephritis

Click through to read more about this announcement

01-08-2022 | Rheumatology | News | Article

FDA approves belimumab for pediatric lupus nephritis

Click through for more information

29-07-2022 | Rheumatology | News | Article

Benefits of risk stratification for musculoskeletal pain questioned

Risk stratification in the primary care setting may not lead to significant improvements in pain or function for people with musculoskeletal disorders, but may have benefits for clinical decision-making, the UK-based STarT MSK trial shows.

Mid section of pregnant woman standing in corridor of hospital (symbolic image with model)

28-07-2022 | Rheumatology | News | Article

TNF inhibitor use during pregnancy linked to higher infant birthweight

Tumor necrosis factor inhibitor use by pregnant women with well-controlled rheumatoid arthritis is associated with a reduced risk for having a child that is born small for gestational age, study findings indicate.

26-07-2022 | Rheumatology | News | Article

Tirzepatide on course for European marketing authorization

Click through to read more on this announcement


26-07-2022 | Rheumatology | News | Article

Botulinum toxin A injection may ease base-of-thumb osteoarthritis pain

Intra-articular injection with botulinum toxin A results in clinically meaningful pain reduction for up to 3 months in people with base-of-thumb osteoarthritis, French study findings indicate.

25-07-2022 | Rheumatology | News | Article

NICE recommends guselkumab for broader PsA population

Click through for more information on this announcement

22-07-2022 | Rheumatology | News | Article

Meta-analysis does not support viscosupplementation for knee osteoarthritis

Findings from a systematic review and meta-analysis indicate that viscosupplementation does not significantly improve pain and physical function in people with knee osteoarthritis, but increases the risk for serious adverse events.

22-07-2022 | Rheumatology | News | Article

Leflunomide shows promise in lupus nephritis

Leflunomide, a DMARD used in the treatment of rheumatoid arthritis, is noninferior to azathioprine for the prevention of kidney flares in people with lupus nephritis, Chinese researchers report.

21-07-2022 | Rheumatology | News | Article

VTE may be ‘recurrent comorbidity’ in granulomatosis with polyangiitis

Recurrent venous thromboembolism is more common in people with granulomatosis with polyangiitis than among individuals in the general population who had an unprovoked first event, US researchers report in Rheumatology Advances in Practice.


19-07-2022 | Rheumatology | News | Article

Bimekizumab demonstrates sustained benefits in PsA, ankylosing spondylitis

Follow-up results from the BE ACTIVE and BE AGILE phase 2b trials show that the efficacy and safety profiles of bimekizumab are maintained for up to 3 years in patients with psoriatic arthritis or ankylosing spondylitis.

18-07-2022 | Rheumatology | News | Article

LOTUS trial suggests no benefit of ustekinumab in SLE

Development of ustekinumab as a potential therapeutic option for systemic lupus erythematosus has been terminated following an interim analysis of the phase 3 LOTUS trial, which demonstrated no benefit of the IL-12/23 inhibitor in this patient population.